Literature DB >> 2153495

Mineralocorticoid activity of carbenoxolone: contrasting effects of carbenoxolone and liquorice on 11 beta-hydroxysteroid dehydrogenase activity in man.

P M Stewart1, A M Wallace, S M Atherden, C H Shearing, C R Edwards.   

Abstract

1. 11-beta-Hydroxysteroid dehydrogenase is an enzyme complex consisting of 11 beta-dehydrogenase and 11-oxoreductase responsible for the interconversion of cortisol to cortisone in man. Inhibition of 11 beta-dehydrogenase (e.g. after liquorice ingestion) results in cortisol acting as a potent mineralocorticoid. We have evaluated the effect of the synthetic liquorice derivative, carbenoxolone, on this enzyme complex. 2. Carbenoxolone given to six volunteers in metabolic balance produced sodium retention with suppression of the renin-angiotensin-aldosterone system. Plasma potassium fell, although there was no kaliuresis. This was associated with inhibition of 11 beta-dehydrogenase (as measured by a rise in the plasma half-life of [11 alpha-3H]cortisol). Unlike liquorice, however, carbenoxolone also inhibited 11-oxoreductase (as measured by the generation of cortisol after oral cortisone acetate). 3. The mineralocorticoid activity of carbenoxolone, like liquorice, is mediated via cortisol by inhibition of 11 beta-dehydrogenase. Carbenoxolone, however, also inhibits 11-oxoreductase activity and this may relate to its effect on renal potassium excretion.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2153495     DOI: 10.1042/cs0780049

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  19 in total

Review 1.  Apparent mineralocorticoid excess syndromes.

Authors:  M Shimojo; P M Stewart
Journal:  J Endocrinol Invest       Date:  1995 Jul-Aug       Impact factor: 4.256

2.  Persistent hypokalemia after successful adrenalectomy in a patient with Cushing's syndrome due to ectopic ACTH secretion: possible role of 11beta-hydroxysteroid dehydrogenase inhibition.

Authors:  E Arteaga; C Fardella; C Campusano; I Cárdenas; P Martinez
Journal:  J Endocrinol Invest       Date:  1999-12       Impact factor: 4.256

3.  Steroid disorders in children: congenital adrenal hyperplasia and apparent mineralocorticoid excess.

Authors:  M I New; R C Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

4.  Glycyrrhizic acid (GCA) as 11β-hydroxysteroid dehydrogenase inhibitor exerts protective effect against glucocorticoid-induced osteoporosis.

Authors:  Elvy Suhana Mohd Ramli; Farihah Suhaimi; Siti Fadziyah Mohamad Asri; Fairus Ahmad; Ima Nirwana Soelaiman
Journal:  J Bone Miner Metab       Date:  2012-12-30       Impact factor: 2.626

5.  Evidence for expression of 11β-hydroxysteroid dehydrogenase type3 (HSD11B3/HSD11B1L) in neonatal pig testis.

Authors:  Shuji Ohno; Satomi Nakagawara; Yoko Honda; Shizuo Nakajin
Journal:  Mol Cell Biochem       Date:  2013-06-04       Impact factor: 3.396

6.  Liver upregulation of genes involved in cortisol production and action is associated with metabolic syndrome in morbidly obese patients.

Authors:  Esther Torrecilla; Gumersindo Fernández-Vázquez; David Vicent; Franco Sánchez-Franco; Ana Barabash; Lucio Cabrerizo; Andrés Sánchez-Pernaute; Antonio J Torres; Miguel Angel Rubio
Journal:  Obes Surg       Date:  2012-03       Impact factor: 4.129

Review 7.  The epithelial sodium channel in hypertension.

Authors:  D G Warnock
Journal:  Curr Hypertens Rep       Date:  1999 Apr-May       Impact factor: 5.369

8.  11Beta-hydroxysteroid dehydrogenase inhibition improves cognitive function in healthy elderly men and type 2 diabetics.

Authors:  Thekkepat C Sandeep; Joyce L W Yau; Alasdair M J MacLullich; June Noble; Ian J Deary; Brian R Walker; Jonathan R Seckl
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-07       Impact factor: 11.205

9.  Reinvestigation of the effect of carbenoxolone on the induction of heat shock proteins.

Authors:  Daisuke Kawashima; Midori Asai; Kiyoe Katagiri; Rika Takeuchi; Kenzo Ohtsuka
Journal:  Cell Stress Chaperones       Date:  2009-03-31       Impact factor: 3.667

10.  Inhibition of 11beta-hydroxysteroid dehydrogenase type 1 activity in vivo limits glucocorticoid exposure to human adipose tissue and decreases lipolysis.

Authors:  Jeremy W Tomlinson; Mark Sherlock; Beverley Hughes; Susan V Hughes; Fiona Kilvington; William Bartlett; Rachel Courtney; Paul Rejto; William Carley; Paul M Stewart
Journal:  J Clin Endocrinol Metab       Date:  2007-01-02       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.